{
    "clinical_study": {
        "@rank": "94056", 
        "arm_group": [
            {
                "arm_group_label": "B0", 
                "arm_group_type": "Experimental", 
                "description": "(basal rate 0cc/hr, bolus 3cc, lockout time 10min)"
            }, 
            {
                "arm_group_label": "BL", 
                "arm_group_type": "Active Comparator", 
                "description": "(basal rate 1cc/hr, bolus 2cc, lockout time 10min)"
            }, 
            {
                "arm_group_label": "BH", 
                "arm_group_type": "Active Comparator", 
                "description": "(basal rate 2cc/hr, bolus 1cc, lockout time 10min)"
            }
        ], 
        "brief_summary": {
            "textblock": "Fentanyl based intravenous patient controlled analgesia(PCA)is popular method for\n      postoperative pain control, but information regarding optimal dose of fentanyl in IV PCA is\n      currently lacking. We thus determine appropriate dose of fentanyl (bolus dose and background\n      infusion rate) for effective pain control with minimal side effects such as nausea and\n      vomiting"
        }, 
        "brief_title": "Comparison of Analgesic Efficacy and Occurrence of Emesis Among Different Background Infusion and Bolus Administration Regimens of Fentanyl Based Intravenous Patient-controlled Analgesia in Patients After Laparoscopic Assisted Gastrectomy - a Randomized Blind Study -", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "The Patients With Gastric Cancer Who Are Scheduled to Receive Laparoscopy Assisted Gastrectomy", 
        "condition_browse": {
            "mesh_term": "Stomach Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age between 20 and 70\n\n          -  ASA class I and II\n\n          -  Gastric cancer patients who are scheduled to receive laparoscopic gastrectomy\n\n        Exclusion Criteria:\n\n          -  Cardiovascular disease(uncontrolled hypertension, unstable angina, congestive heart\n             failure, etc.)\n\n          -  Renal failure\n\n          -  Liver failure\n\n          -  Chronic drug or alcohol abuser\n\n          -  Anti-cancer chemotherapy\n\n          -  Chronic opioid use\n\n          -  Use of antiemetics within 24hrs for nausea and vomiting"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "225", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01863355", 
            "org_study_id": "4-2013-0176"
        }, 
        "intervention": [
            {
                "arm_group_label": "B0", 
                "intervention_name": "B0 group: bolus 0.6mcg/kg without background infusion", 
                "intervention_type": "Drug", 
                "other_name": "Fentanyl based intraveonus patient controlled analgesia"
            }, 
            {
                "arm_group_label": "BL", 
                "intervention_name": "BL group: bolus 0.4mcg/kg with background infusion rate 0.2mcg/kg/hr", 
                "intervention_type": "Drug", 
                "other_name": "Fentanyl based intraveonus patient controlled analgesia"
            }, 
            {
                "arm_group_label": "BH", 
                "intervention_name": "BH group: bolus 0.2mcg/kg with background infusion rate 0.4mcg/kg/hr", 
                "intervention_type": "Drug", 
                "other_name": "Fentanyl based intraveonus patient controlled analgesia"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Fentanyl"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "IntravenousPCA, fentanyl, postoperative pain, laparoscopic gastrectomy", 
        "lastchanged_date": "May 22, 2013", 
        "location": {
            "contact": {
                "email": "sanctum@yuhs.ac", 
                "last_name": "Kwan-woong Choi", 
                "phone": "(82) 2-2227-4613"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Severance Hospital, Yonsei University Health System"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "3", 
        "overall_contact": {
            "email": "sanctum@yuhs.ac", 
            "last_name": "Kwan-woong Choi", 
            "phone": "(82) 2-2227-4613"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Korea Food and Drug Administration (KFDA)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pain score after surgery within 48hrs after laparoscopic gastrectomy", 
            "measure": "Pain score(VAS) within 48hrs after surgery", 
            "safety_issue": "No", 
            "time_frame": "Pain socre after surgery 1) within 30min-6hrs, 2) within 6-24hrs, 3) within 24hrs-48hrs"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01863355"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}